Log in or Sign up for Free to view tailored content for your specialty!
Pediatric ID News
In survey, many parents report not adhering to COVID-19 guidelines
Around one-quarter of surveyed parents reported not adhering to a public health measures against COVID-19.
Longer interval between COVID-19 vaccine doses could improve protection
A longer interval between doses of COVID-19 vaccine in children aged 5 to 11 years was associated with higher effectiveness against symptomatic infection, according to a real-world study published in Pediatrics.
Log in or Sign up for Free to view tailored content for your specialty!
HPV vaccination rate improves but many parents remain hesitant
The rate of teenagers vaccinated against HPV is improving but a significant number of parents remain hesitant about their children receiving the vaccine, a study found.
World needs a better pertussis vaccine, expert argues
A pediatric infectious disease expert made the case that the world needs a better pertussis vaccine.
Hospital identifies variables associated with maternal, congenital syphilis
Researchers reviewed a decade of maternal and congenital syphilis cases at a Brooklyn hospital and identified two variables associated with infection: racial identities other than Black or white and low socioeconomic status.
‘Reach the children being left behind’: WHO official eyes future of pediatric care
A WHO official speaking at the St. Jude/PIDS Pediatric Infectious Diseases Research Conference encouraged health care communities to “reach the children being left behind.”
Study: Moving HPV vaccine initiation to age 9 or 10 could improve coverage
Routine HPV vaccination rates could be improved if children were vaccinated earlier, according to a new study.
Study finds disparities in pediatric care disruption during pandemic
Urban families, Black and multiracial children and families with low socioeconomic status faced the highest rates of pediatric care disruption during the COVID-19 pandemic, a study found.
Pfizer presents data to CDC on maternal RSV vaccine up for FDA review
Pfizer presented data for the first time publicly Thursday on its maternal vaccine candidate for respiratory syncytial virus, which was granted priority review this week by the FDA.
Early data indicate flu vaccine offered significant protection
Preliminary estimates published Thursday in MMWR and presented this week by the CDC indicate that this season’s influenza vaccine offered significant protection among all ages.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read